SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (2403)3/25/2000 6:01:00 PM
From: Mark Marcellus  Read Replies (1) of 5582
 
I believe that some people are too focused on Zicam, because this company has a lot more going for it than just that one product. I think that this focus has hurt the stock price in the short term, and that the stock will rally when people realize that production of nicotine gum will begin in only three to six months. I believe that the company is also very close to announcing a joint venture for a new dental gum (major toothpaste brand).

Dan, that sure doesn't jibe with what you were saying a few weeks ago. Statements like the above coming from a company spokesman would always make me suspicious, but for a company with GUMM's track record, they are a big red warning flag. The history of this company has been one promised blockbuster product after another. And each time the blockbuster doesn't materialize, we get promised yet another one.

It's starting to sound like deja vu all over again to me.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext